Home > Publications database > Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. > print |
001 | 120023 | ||
005 | 20240228135007.0 | ||
024 | 7 | _ | |a 10.1158/2159-8290.CD-13-0349 |2 doi |
024 | 7 | _ | |a pmid:24356097 |2 pmid |
024 | 7 | _ | |a pmc:PMC4134522 |2 pmc |
024 | 7 | _ | |a 2159-8274 |2 ISSN |
024 | 7 | _ | |a 2159-8290 |2 ISSN |
024 | 7 | _ | |a altmetric:2135604 |2 altmetric |
037 | _ | _ | |a DKFZ-2017-00611 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Oakes, Christopher C |0 P:(DE-HGF)0 |b 0 |e First author |
245 | _ | _ | |a Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. |
260 | _ | _ | |a Philadelphia, Pa. |c 2014 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1490701717_15175 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of epigenetic alterations to promote tumor evolution is undefined. We used 450k arrays and next-generation sequencing to evaluate intratumor heterogeneity and evolution of DNA methylation and genetic aberrations in chronic lymphocytic leukemia (CLL). CLL cases exhibit vast interpatient differences in intratumor methylation heterogeneity, with genetically clonal cases maintaining low methylation heterogeneity and up to 10% of total CpGs in a monoallelically methylated state. Increasing methylation heterogeneity correlates with advanced genetic subclonal complexity. Selection of novel DNA methylation patterns is observed only in cases that undergo genetic evolution, and independent genetic evolution is uncommon and is restricted to low-risk alterations. These results reveal that although evolution of DNA methylation occurs in high-risk, clinically progressive cases, positive selection of novel methylation patterns entails coevolution of genetic alteration(s) in CLL. |
536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Claus, Rainer |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Gu, Lei |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Assenov, Yassen |0 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c |b 3 |u dkfz |
700 | 1 | _ | |a Hüllein, Jennifer |0 P:(DE-He78)c9be4ab60d1090c3d315a2ca6905e9ea |b 4 |u dkfz |
700 | 1 | _ | |a Zucknick, Manuela |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Bieg, Matthias |0 P:(DE-He78)e247efc0264a7b0e4bae09804002d4e1 |b 6 |u dkfz |
700 | 1 | _ | |a Brocks, David |0 P:(DE-He78)3860e24c3868c15255c3383a58e8d5b8 |b 7 |u dkfz |
700 | 1 | _ | |a Bogatyrova, Olga |0 P:(DE-He78)3493620cedb8f0b17c9e1b424c0e21db |b 8 |u dkfz |
700 | 1 | _ | |a Schmidt, Christopher R |0 P:(DE-HGF)0 |b 9 |
700 | 1 | _ | |a Rassenti, Laura |b 10 |
700 | 1 | _ | |a Kipps, Thomas J |b 11 |
700 | 1 | _ | |a Mertens, Daniel |0 P:(DE-He78)833c06a995d272b78f3a20df3eba6e9e |b 12 |u dkfz |
700 | 1 | _ | |a Lichter, Peter |0 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c |b 13 |u dkfz |
700 | 1 | _ | |a Döhner, Hartmut |b 14 |
700 | 1 | _ | |a Stilgenbauer, Stephan |b 15 |
700 | 1 | _ | |a Byrd, John C |b 16 |
700 | 1 | _ | |a Zenz, Thorsten |0 P:(DE-He78)f3d5f16b49eb47520def635be98d5576 |b 17 |u dkfz |
700 | 1 | _ | |a Plass, Christoph |0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |b 18 |e Last author |u dkfz |
773 | _ | _ | |a 10.1158/2159-8290.CD-13-0349 |g Vol. 4, no. 3, p. 348 - 361 |0 PERI:(DE-600)2607892-2 |n 3 |p 348 - 361 |t Cancer discovery |v 4 |y 2014 |x 2159-8290 |
909 | C | O | |o oai:inrepo02.dkfz.de:120023 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)c9be4ab60d1090c3d315a2ca6905e9ea |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)e247efc0264a7b0e4bae09804002d4e1 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)3860e24c3868c15255c3383a58e8d5b8 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)3493620cedb8f0b17c9e1b424c0e21db |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)833c06a995d272b78f3a20df3eba6e9e |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)f3d5f16b49eb47520def635be98d5576 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2014 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER DISCOV : 2015 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b CANCER DISCOV : 2015 |
920 | 1 | _ | |0 I:(DE-He78)C010-20160331 |k C010 |l Epigenomik und Krebsrisikofaktoren |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B080-20160331 |k B080 |l Theoretische Bioinformatik |x 1 |
920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l Biostatistik |x 2 |
920 | 1 | _ | |0 I:(DE-He78)B060-20160331 |k B060 |l Molekulare Genetik |x 3 |
920 | 1 | _ | |0 I:(DE-He78)G100-20160331 |k G100 |l Translationale Onkologie |x 4 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C010-20160331 |
980 | _ | _ | |a I:(DE-He78)B080-20160331 |
980 | _ | _ | |a I:(DE-He78)C060-20160331 |
980 | _ | _ | |a I:(DE-He78)B060-20160331 |
980 | _ | _ | |a I:(DE-He78)G100-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|